Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
9
90%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed3
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (10.0%)
N/A9 (90.0%)

Trials by Status

not_yet_recruiting220%
terminated110%
completed330%
unknown440%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10